Ticovac 1.2MCG/0.25 1S
Ended Awarded
- Contract number
- SPE2DR26FBTBS
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,658
Award facts
- Contract value 100% obligated
- $1,658.24 Current and potential, with all options
- Completion date
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $1,658.24 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for TICOVAC 1.2MCG/0.25 1S vaccine product. The delivery order, issued on November 5, 2025, with an ultimate completion date of the same day, is structured as a firm fixed-price contract with no set-aside designation, indicating the vendor competed on an unrestricted basis. The award represents one of numerous delivery orders issued to DMS Pharmaceutical Group under the Defense Logistics Agency's medical supply chain operations.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion government-wide acquisition strategy. DMS Pharmaceutical Group holds a prime vendor contract designated SPE2DR with a ceiling value of $499,999,999 extending through December 31, 2036, positioning the company as a critical pharmaceutical supplier for Department of Defense healthcare operations worldwide. The PPV-G GEN V program authorizes the issuance of firm fixed-price delivery orders for branded and generic prescription drugs, biologics, vaccines, and medical consumables to support military healthcare facilities, and this TICOVAC vaccine delivery order exemplifies the routine pharmaceutical fulfillment under this broader strategic contracting vehicle.
Quick answers
Who was awarded contract SPE2DR26FBTBS?
SPE2DR26FBTBS was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 5, 2025.
How much is contract SPE2DR26FBTBS worth?
The government has obligated $1,658 on SPE2DR26FBTBS.
Is contract SPE2DR26FBTBS an order under another contract?
Yes. SPE2DR26FBTBS is a delivery order under SPE2DR25D9628, an indefinite delivery contract.
Was contract SPE2DR26FBTBS competed?
The extent of competition for SPE2DR26FBTBS was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award